David Adams

About

David Adams is a Senior Group Leader and Interim Programme Head at the Wellcome Sanger Institute in the UK. His research focuses on various aspects of cancer genomics and environmental influences on cancer development, as highlighted in recent articles examining genetic testing in melanoma, desmosome mutations in keratinocytes, and the relationship between environmental exposure and cancer. Additionally, he has contributed to studies on ocular phenotyping and tumorigenesis mechanisms, reflecting his commitment to advancing understanding in these critical areas of research.